Inge Beernaert appointed President of the Compensation and Nomination CommitteeJacques Galloy appointed President of the Audit Committee Liege, Belgium, 29 May 2023 - 7:30 CEST - Mithra (Euronext Brussels:
Belgium - Mithra , a company dedicated to Women s Health, today announces the appointment of leading life sciences executive Dr.Christian Homsy as Chairman of the Board of Directors.
The Board of. | May 29, 2023
Liege, Belgium, 4 April 2023 - 7:00 CET - Mithra , a company dedicated to Women s Health, appoints Dr. David H Solomon as Chief Executive Officer starting on April 11th, 2023. This follows the. | April 4, 2023
Share this article
Share this article
LIEGE, Belgium, June 3, 2021 /PRNewswire/ Amyl Therapeutics ( Amyl ), a preclinical stage biotechnology company developing its amyloid fibrils specific
technology platform named ClariTY for the treatment of all forms of Amyloidosis, today announced that it has successfully closed a €18.3 million Series A financing. The funding round comprises €8.6 million in equity led by Noshaq - a regional Belgian private-public fund - with support from Merieux Participations, Sambrinvest and other private investors; and €9.7 million in non-dilutive funding from the DG06 – a key policy-design and implementing body for research and innovation policy in the Walloon region of Belgium.